180 related articles for article (PubMed ID: 28872685)
1. Inactivation of Babesia microti in red blood cells and platelet concentrates.
Tonnetti L; Laughhunn A; Thorp AM; Vasilyeva I; Dupuis K; Stassinopoulos A; Stramer SL
Transfusion; 2017 Oct; 57(10):2404-2412. PubMed ID: 28872685
[TBL] [Abstract][Full Text] [Related]
2. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
[TBL] [Abstract][Full Text] [Related]
4. Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.
Tonnetti L; Thorp AM; Reddy HL; Keil SD; Goodrich RP; Leiby DA
Transfusion; 2013 Apr; 53(4):860-7. PubMed ID: 22803831
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of chikungunya virus in blood components treated with amotosalen/ultraviolet A light or amustaline/glutathione.
Laughhunn A; Huang YS; Vanlandingham DL; Lanteri MC; Stassinopoulos A
Transfusion; 2018 Mar; 58(3):748-757. PubMed ID: 29322519
[TBL] [Abstract][Full Text] [Related]
6. Screening for Babesia microti in the U.S. Blood Supply.
Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of the experimental animal model of Babesia microti].
Lu Y; Cai YC; Chen SH; Chen JX; Guo J; Chen MX; Ai L; Chu YH; Chen Z; Zhou XN
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Dec; 30(6):423-7. PubMed ID: 23484250
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry.
Zavizion B; Pereira M; de Melo Jorge M; Serebryanik D; Mather TN; Chapman J; Miller NJ; Alford B; Bzik DJ; Purmal A
Transfusion; 2004 May; 44(5):731-8. PubMed ID: 15104655
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets.
Castro E; González LM; Rubio JM; Ramiro R; Gironés N; Montero E
Transfusion; 2014 Sep; 54(9):2207-16. PubMed ID: 24666393
[TBL] [Abstract][Full Text] [Related]
10. [Effect of transfusing blood components containing
Hui-Min S; Yu-Chun C; Jia-Xu C; Kui-Yang Z
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 Sep; 31(4):423-426. PubMed ID: 31612680
[TBL] [Abstract][Full Text] [Related]
11. Elimination of
Skariah S; Arnaboldi P; Dattwyler RJ; Sultan AA; Gaylets C; Walwyn O; Mulhall H; Wu X; Dargham SR; Mordue DG
J Immunol; 2017 Jul; 199(2):633-642. PubMed ID: 28607116
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.
Lanteri MC; Santa-Maria F; Laughhunn A; Girard YA; Picard-Maureau M; Payrat JM; Irsch J; Stassinopoulos A; Bringmann P
Transfusion; 2020 Jun; 60(6):1319-1331. PubMed ID: 32333396
[TBL] [Abstract][Full Text] [Related]
13. Minimal infectious dose and dynamics of Babesia microti parasitemia in a murine model.
Bakkour S; Chafets DM; Wen L; Muench MO; Telford SR; Erwin JL; Levin AE; Self D; Brès V; Linnen JM; Lee TH; Busch MP
Transfusion; 2018 Dec; 58(12):2903-2910. PubMed ID: 30264498
[TBL] [Abstract][Full Text] [Related]
14. Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell components.
Laughhunn A; Santa Maria F; Broult J; Lanteri MC; Stassinopoulos A; Musso D; Aubry M
Transfusion; 2017 Mar; 57(3pt2):779-789. PubMed ID: 28164306
[TBL] [Abstract][Full Text] [Related]
15. Transmission risk evaluation of transfusion blood containing low-density
Cai Y; Xu B; Liu X; Yang W; Mo Z; Zheng B; Chen J; Hu W
Front Cell Infect Microbiol; 2024; 14():1334426. PubMed ID: 38375363
[TBL] [Abstract][Full Text] [Related]
16. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
[TBL] [Abstract][Full Text] [Related]
17. Comparative pathogenesis of human WA1 and Babesia microti isolates in a Syrian hamster model.
Wozniak EJ; Lowenstine LJ; Hemmer R; Robinson T; Conrad PA
Lab Anim Sci; 1996 Oct; 46(5):507-15. PubMed ID: 8905583
[TBL] [Abstract][Full Text] [Related]
18. Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model.
Gumber S; Nascimento FS; Rogers KA; Bishop HS; Rivera HN; Xayavong MV; Devare SG; Schochetman G; Amancha PK; Qvarnstrom Y; Wilkins PP; Villinger F
Transfusion; 2016 Jun; 56(6 Pt 2):1508-19. PubMed ID: 26892459
[TBL] [Abstract][Full Text] [Related]
19. Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules.
Mousa AA; Roche DB; Terkawi MA; Kameyama K; Kamyingkird K; Vudriko P; Salama A; Cao S; Orabi S; Khalifa H; Ahmed M; Attia M; Elkirdasy A; Nishikawa Y; Xuan X; Cornillot E
PLoS One; 2017; 12(10):e0185372. PubMed ID: 29040286
[TBL] [Abstract][Full Text] [Related]
20. Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani.
Wilson M; Glaser KC; Adams-Fish D; Boley M; Mayda M; Molestina RE
Exp Parasitol; 2015 Feb; 149():24-31. PubMed ID: 25500215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
